These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25815142)

  • 21. Structural insights into SAM domain-mediated tankyrase oligomerization.
    DaRosa PA; Ovchinnikov S; Xu W; Klevit RE
    Protein Sci; 2016 Sep; 25(9):1744-52. PubMed ID: 27328430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. USP25 regulates Wnt signaling by controlling the stability of tankyrases.
    Xu D; Liu J; Fu T; Shan B; Qian L; Pan L; Yuan J
    Genes Dev; 2017 May; 31(10):1024-1035. PubMed ID: 28619731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity.
    Buchstaller HP; Anlauf U; Dorsch D; Kuhn D; Lehmann M; Leuthner B; Musil D; Radtki D; Ritzert C; Rohdich F; Schneider R; Esdar C
    J Med Chem; 2019 Sep; 62(17):7897-7909. PubMed ID: 31381853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleiotropic roles of tankyrase/PARP proteins in the establishment and maintenance of human naïve pluripotency.
    Zimmerlin L; Zambidis ET
    Exp Cell Res; 2020 May; 390(1):111935. PubMed ID: 32151493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions.
    Kirubakaran P; Kothandan G; Cho SJ; Muthusamy K
    Mol Biosyst; 2014 Feb; 10(2):281-93. PubMed ID: 24291818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based design of 2-aminopyridine oxazolidinones as potent and selective tankyrase inhibitors.
    Huang H; Guzman-Perez A; Acquaviva L; Berry V; Bregman H; Dovey J; Gunaydin H; Huang X; Huang L; Saffran D; Serafino R; Schneider S; Wilson C; DiMauro EF
    ACS Med Chem Lett; 2013 Dec; 4(12):1218-23. PubMed ID: 24900633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-efficiency relationship of [1,2,4]triazol-3-ylamines as novel nicotinamide isosteres that inhibit tankyrases.
    Shultz MD; Majumdar D; Chin DN; Fortin PD; Feng Y; Gould T; Kirby CA; Stams T; Waters NJ; Shao W
    J Med Chem; 2013 Sep; 56(17):7049-59. PubMed ID: 23879431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel binding mode of a potent and selective tankyrase inhibitor.
    Gunaydin H; Gu Y; Huang X
    PLoS One; 2012; 7(3):e33740. PubMed ID: 22438990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities.
    Zamudio-Martinez E; Herrera-Campos AB; Muñoz A; Rodríguez-Vargas JM; Oliver FJ
    J Exp Clin Cancer Res; 2021 Apr; 40(1):144. PubMed ID: 33910596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unravelling the Mechanistic Role of Quinazolinone Pharmacophore in the Inhibitory Activity of Bis-quinazolinone Derivative on Tankyrase-1 in the Treatment of Colorectal Cancer (CRC) and Non-small Cell Lung Cancer (NSCLC): A Computational Approach.
    Okunlola FO; Akawa OB; Subair TI; Omolabi KF; Soliman MES
    Cell Biochem Biophys; 2022 Mar; 80(1):1-10. PubMed ID: 34453681
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Loganathan L; Muthusamy K; Jayaraj JM; Kajamaideen A; Balthasar JJ
    J Biomol Struct Dyn; 2019 Sep; 37(14):3637-3648. PubMed ID: 30204055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of a Novel Triazolopyridine Derivative as a Tankyrase Inhibitor.
    Ryu H; Nam KY; Kim HJ; Song JY; Hwang SG; Kim JS; Kim J; Ahn J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors.
    Haikarainen T; Narwal M; Joensuu P; Lehtiö L
    ACS Med Chem Lett; 2014 Jan; 5(1):18-22. PubMed ID: 24900770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tankyrases as drug targets.
    Lehtiö L; Chi NW; Krauss S
    FEBS J; 2013 Aug; 280(15):3576-93. PubMed ID: 23648170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
    Bregman H; Chakka N; Guzman-Perez A; Gunaydin H; Gu Y; Huang X; Berry V; Liu J; Teffera Y; Huang L; Egge B; Mullady EL; Schneider S; Andrews PS; Mishra A; Newcomb J; Serafino R; Strathdee CA; Turci SM; Wilson C; DiMauro EF
    J Med Chem; 2013 Jun; 56(11):4320-42. PubMed ID: 23701517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scaffold hopping approach on the route to selective tankyrase inhibitors.
    Liscio P; Carotti A; Asciutti S; Ferri M; Pires MM; Valloscuro S; Ziff J; Clark NR; Macchiarulo A; Aaronson SA; Pellicciari R; Camaioni E
    Eur J Med Chem; 2014 Nov; 87():611-23. PubMed ID: 25299683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tankyrase Inhibition Attenuates Cardiac Dilatation and Dysfunction in Ischemic Heart Failure.
    Wang H; Segersvärd H; Siren J; Perttunen S; Immonen K; Kosonen R; Chen YC; Tolva J; Laivuori M; Mäyränpää MI; Kovanen PT; Sinisalo J; Laine M; Tikkanen I; Lakkisto P
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of Tankyrase Inhibitor-Induced Degradasomes Requires Proteasome Activity.
    Pedersen NM; Thorvaldsen TE; Schultz SW; Wenzel EM; Stenmark H
    PLoS One; 2016; 11(8):e0160507. PubMed ID: 27482906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt.
    Regmi SC; Park SY; Kim SJ; Banskota S; Shah S; Kim DH; Kim JA
    PLoS One; 2015; 10(11):e0141753. PubMed ID: 26544726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition.
    Scarborough HA; Helfrich BA; Casás-Selves M; Schuller AG; Grosskurth SE; Kim J; Tan AC; Chan DC; Zhang Z; Zaberezhnyy V; Bunn PA; DeGregori J
    Clin Cancer Res; 2017 Mar; 23(6):1531-1541. PubMed ID: 27663586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.